Vivo Capital Fund VIII, L.P. 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-13 6:48 pm Purchase | 2025-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital Fund VIII, L.P. | 72,414 3.800% | 72,414 (New Position) | Filing |